Ana Plaza Arregui

Vicepresident And President Of The Audit Committee at Asociación Española contra el Cáncer

Ana Plaza Arregui has held various positions throughout their career. Ana has served as a Non-Executive Director and President of the Audit Committee at multiple companies, including GLOBALVIA, Linea Directa Aseguradora, and Corporacion Financiera Alba SA. Additionally, they have been a member of the Advisory Board at Fundación Innovación Bankinter and Vice President and President of the Audit Committee at Asociación Española contra el Cáncer (AECC). Ana has also served as a Non-Executive Director and President of the Audit Committee at Groupe Renault España. In terms of education, Ana Plaza Arregui has been a Non-Executive Director and member of the Permanent Committee at Universidad Loyola Andalucía. Ana has also held executive positions, such as Managing Director at IMMUNE Coding Institute and Director General at Confederación Española de Organizaciones Empresariales (CEOE). Throughout their career, they have shown expertise in leadership, organizational restructuring, and promoting business growth.

Ana Plaza Arregui has a diverse education history. In 1986-1991, they obtained a degree in Licenciada en CC.CC. económicas y Empresariales from the Universidad de Córdoba. In 1999-2000, they completed the Programa de Desarrollo de Directivos (PDD) from IESE Business School. Later, in 2007, they attended the Harvard Kennedy School for a course on Global Leadership and Public Policy for the 21st century. In 2016, Ana Plaza Arregui participated in the Programa de Alta Dirección en Digital Business at The Valley Digital Business School. In 2018, they completed the Programa para Consejeros at Esade. Additionally, Ana Plaza Arregui has obtained several certifications, including FSA Credential Level II Candidate from SASB Standards in 2021, AI0101SP: Inteligencia Artificial para todos: Domina las bases from edX in 2021, and Critical Thinking for Better Judgment and Decision-Making from LinkedIn in 2021.

Links

Previous companies

IMMUNE Technology Institute logo